Is Ritonavir-boosted Protease Inhibitors (PIs/r) monotherapy noninferior to classic combined antiretroviral therapy (cART)?

The main purpose of this paper was to give an overview of all ritonavir-boosted PI (PI/r) monotherapy studies published in peer-reviewed medical journals or presented at international HIV conferences and assess its efficacy in comparison to the traditional cART.